On Oct. 29, the U.S. Food and Drug Administration (FDA) approved Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal…
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an…
On Oct. 15, the U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm and Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis.…
Access ebola information from the American Nurses Association (ANA) http://www.nursingworld.org/MainMenuCategories/WorkplaceSafety/Healthy-Work-Environment/DPR/Ebola-Information.html.
On Oct. 1, the U.S. Food and Drug Administration (FDA) finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient health and…
The Centers for Disease Control and Prevention (CDC) has dedicated a section of its website to the nationwide outbreak of enterovirus D68 (EV-D68) associated…
Researchers have found that medicines called JAK inhibitors halted tumor growth in patients with colon cancer who had a genetic mutation that is present…
On Oct. 17, the U.S. Food and Drug Administration (FDA) approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER)…
On Oct. 15, the U.S. Food and Drug Administration (FDA) approved Ofev (nintedanib) http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm and Esbriet (pirfenidone) for the treatment of idiopathic…
Access ebola information from the American Nurses Association (ANA) http://www.nursingworld.org/MainMenuCategories/WorkplaceSafety/Healthy-Work-Environment/DPR/Ebola-Information.html.
On Oct. 1, the U.S. Food and Drug Administration (FDA) finalized recommendations to manufacturers for managing cybersecurity risks to better protect patient…